SCHEMBL18137163

SCHEMBL18137163

C=C(CC1CC1)Nc1nnc(CCCCc2nnc(NC(=O)CC3CC3)s2)s1

nearest known ligand 0.85

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 16/20 0.85
▸ ALDH1A1 P00352 1/20 0.49
▸ CA2 P00918 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14986949 0.92 GLS (1.00) GLSALDH1A1CA2
SCHEMBL15727744 0.87 GLS (0.89) GLSALDH1A1CA2
SCHEMBL14987001 0.87 GLS (0.89) GLSALDH1A1CA2
SCHEMBL14987262 0.83 GLS (0.82) GLSALDH1A1CA2
SCHEMBL16384868 0.81 GLS (0.78) GLSALDH1A1CA2
SCHEMBL14987443 0.80 GLS (1.00) GLS
SCHEMBL15042405 0.77 GLS (0.88) GLSALDH1A1CA2
SCHEMBL14987258 0.77 GLS (0.70) GLSALDH1A1CA2
SCHEMBL21484237 0.76 GLS (0.68) GLSALDH1A1CA2
SCHEMBL14986996 0.75 GLS (0.90) GLSALDH1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016164401-A1 TREATMENT OF LUNG CANCER WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2016-10-13 — — WO disclosed
Send feedback